Who's buying CytoMed Therapeutics Ltd?

GDTC insider buying, 13F and 13D filings

• Oct 16, 202613D stake (no activist plan)
  Choo Chee Kong: Amended Schedule 13D: 25.2% stake
  Mr. Choo Chee Kong has acquired all of the Ordinary Shares beneficially owned by him (1) in exchange for capital contributions to the Issuer or (2) through public purchases on the open market with his personal funds for investment purposes. The Reporting Person serves as Chairman… (2 filings on record; latest shown.)
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.